Response of systemic amyloidosis to dimethyl sulfoxide.
A 65-year-old women with systemic amyloidosis was given dimethyl sulfoxide orally for 4 years without significant side effects. Her cutaneous lesions improved markedly after the treatment, and she still survives in satisfactory condition.
D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy* / Q000473:pathology; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D012867:Skin / Q000473:pathology
D004121:Dimethyl Sulfoxide